From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona’s bioscience industry has grown in recent years and by 2014 state bioscience firms employed just over 24,000 in nearly 1,300 business establishments. Four of the state’s five bioscience subsectors have contributed to its 2 percent overall employment gain since 2012, led by double-digit job growth in medical devices (up 11 percent). State academic institutions accounted for nearly $400 million in bioscience-related R&D expenditures in 2014 and NIH funding to these and other non-academic institutions totaled $150.6 million in 2015. Arizona inventors have had 1,751 patents issued in bioscience-related classes since 2012, primarily in medical and surgical devices but also in drugs and pharmaceuticals, microbiology and genetics, and in biochemistry. The state has seen a strong increase in venture capital invested in bioscience-related companies in recent years. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
October 20, 2011 , WASHINGTON, D.C. Ann-Marie Lynch, executive vice president of the Advanced Medical Technology Association (AdvaMed), released the following statement regarding the Centers for Medicare and Medicaid Services (CMS) final rule on Accountable Care Organizations (ACOs):
Phoenix’s VisionGate Inc has raised $2 million in the first portion of equity financing raised from existing and new investors. The company has developed a non-invasive test for the early detection of lung cancer using 3D cell imaging from a single sputum sample.
As seen on the 360 Vantage Blog Our sincerest thanks to Joan Koerber-Walker, CEO of AZBio, and her entire team for their outstanding leadership in putting together last week’s AZBio EXPO and Awards Dinner. This annual event was truly the state’s premier gathering of innovators and leaders in the bioscience community, and we were extremely […]
SynCardia Named “Arizona Bioscience Company of the Year” (Source: Syncardia)
- MedCity CONVERGE Cancer Conference
- 07/31/2017 - 08/01/2017
- Focusing on the Cure: CAR T Strategies
- Chemical Development of Anticancer Drugs
- Microfluidics and Nanotechnology Tools for Early Diagnosis and Therapy of Cancer
- After Hours Networking with the AZBio Board